BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,998.74
      -0.38%
      US Tech 100
      20,240.00
      -0.65%
      Dow Jones
      44,722.06
      -0.31%
      Brent Oil
      72.365
      -0.43%
      Bitcoin
      95,523.60
      -0.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Olema Pharmaceuticals Inc (OLMA)

      7. Olema Pharmaceuticals Inc (OLMA) Financials

      Olema Pharmaceuticals Inc

      Olema Pharmaceuticals Inc (OLMA)

      NASDAQ
      10.12
      0.40
      (4.12%)
      Closed November 28 4:00PM
      Delayed by 15 minutes
      10.12
      0.00
      (0.00%)
      After Hours: 5:19PM
      Delayed by 15 minutes

      Olema Pharmaceuticals Inc Financial Summary

      The current OLMA market cap is 579.85M. The company's latest EPS is USD -1.6869 and P/E is -6.00.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -21.6M-23.34M-30.42M-34.34M-33.53M
      Net Income -20.1M-21.5M-26.77M-30.97M-30.38M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.32M-21.53M-71.49M-106.99M-104.96M
      Net Income -4.32M-23.99M-71.1M-104.79M-96.66M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 177.62M292.8M276.95M263.69M254.56M
      Total Liabilities 16.04M17.67M23.05M27.38M27.39M
      Total Equity 161.58M275.13M253.9M236.32M227.16M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 132k342.72M295.95M215.65M276.95M
      Total Liabilities 1.38M4.59M11.38M18.1M23.05M
      Total Equity -10.59M338.14M284.57M197.55M253.9M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -42.51M-65.25M-83.73M-23.5M-51.05M
      Investing 51.5M26.06M-4.85M-20.14M-25.02M
      Financing 2.26M132.89M133.42M8.82M24.43M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.08M-19.87M-50.69M-82.07M-83.73M
      Investing N/A -56k-275.44M91.48M-4.85M
      Financing N/A 358.4M1.39M476k133.42M

      Stats and Ratios

      Market Cap 579.85M
      Price to Earnings Ratio -6.00
      Price to Sales Ratio 0
      Price to Cash Ratio 8.46
      Price to Book Ratio 2.28
      Dividend Yield -

      Share Statistics

      Shares Outstanding 57.3M
      Average Volume (1 week) 931.03k
      Average Volume (1 Month) 605.4k
      52 Week Change -30.06%
      52 Week High 16.775
      52 Week Low 7.675
      Spread (Intraday) 1.39 (12.85%)

      Company Info

      Company Name Olema Pharmaceuticals Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://olema.com
      Industry pharmaceutical preparations (2834)